| 000 | 01116nam a2200277Ia 4500 | ||
|---|---|---|---|
| 008 | 191130s1998##################000#0#eng## | ||
| 020 | _a9780792381471 | ||
| 022 | _a98015948 | ||
| 040 |
_aACL _cACL |
||
| 082 | _a616.12061 DHA | ||
| 245 |
_aAngiotensin II receptor blockade : physiological and clinical implications _cedited by Naranjan S. Dhalla ... [et al.] |
||
| 260 |
_aBoston _bKluwer Academic Publishers _cc1998 |
||
| 300 | _axlii, 588 p. : ill. ; 25 cm | ||
| 500 | _aIncludes bibliographical references and index | ||
| 650 | _aAngiotensin converting enzyme - Inhibitors - Congresses | ||
| 650 | _aAngiotensin II - physiology - congresses | ||
| 650 | _aAngiotensins - Congresses | ||
| 650 | _aHeart Diseases - drug therapy - congresses | ||
| 650 | _aHypertension - drug therapy - congresses | ||
| 650 | _aReceptors, Angiotensin - antagonists & inhibitors - congresses | ||
| 700 | _aDhalla, Naranjan S | ||
| 710 | _aManitoba Cardovascular Forum on Angiotensin Receptor Blockade (1996 : Winnipeg, Man.) | ||
| 990 | _aade553afac10000c6d3ddfe3b261aa62 | ||
| 991 | _a109296 | ||
| 999 |
_c370392 _d370392 |
||